EXHIBIT ___
SETTLEMENT AGREEMENT
I. PRELIMINARY STATEMENT
A. PARTIES. The parties to this Settlement Agreement are Acacia
Research Corporation ("Acacia") and Whitewing Labs, Inc. ("Whitewing") on the
one hand, and ▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and ▇▇▇ ▇. ▇▇▇▇▇▇ (collectively, the
"▇▇▇▇▇▇") on the other hand.
B. RECITALS. This Settlement Agreement is entered into with respect to
the following facts:
(1) In or about October 1993, the ▇▇▇▇▇▇ became employed by ▇▇▇▇▇▇.
At or around the same time, ▇▇▇ ▇▇▇▇▇▇ became an officer and director of
Acacia, and an officer of Whitewing. (▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ contends that he
too was a director of Acacia, but Acacia disagrees.) As part of their
compensation packages, ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ received options to purchase
50,000 shares of Acacia common stock at $2.00 per share, and ▇▇▇ ▇▇▇▇▇▇
received options to purchase 50,000 shares of Acacia common stock at $2.00
per share and options to purchase 10,000 shares of Whitewing common stock
at $.133 per share (collectively the "Stock Options").
(2) In or about October 1994, the ▇▇▇▇▇▇'▇ employment by ▇▇▇▇▇▇ was
terminated, and they resigned from all of their positions at Acacia and
Whitewing. In or about November 1994, Acacia, ▇▇▇▇▇▇▇▇▇, and the ▇▇▇▇▇▇
executed a Termination and Consulting Agreement (the "Termination
Agreement") which, among other things, purported to confirm the continuing
validity of the Stock Options.
(3) In February 1996, ▇▇▇ ▇▇▇▇▇▇ attempted to exercise her Stock
Options to purchase Whitewing common stock. In March 1996, Acacia and
▇▇▇▇▇▇▇▇▇ informed the ▇▇▇▇▇▇ that the companies believed the Stock Options
and Termination Agreement were null and void because they had been obtained
through fraud and duress. As a result, ▇▇▇▇▇▇▇▇▇ refused to permit ▇▇▇
▇▇▇▇▇▇ to exercise any of her Stock Options to purchase Whitewing common
stock.
(4) In May 1996, the ▇▇▇▇▇▇ attempted to exercise 10,000 of their
100,000 Stock Options to purchase Acacia common stock. ▇▇▇▇▇▇ refused to
permit the ▇▇▇▇▇▇ to exercise any of these Stock Options.
(5) In August 1996, the ▇▇▇▇▇▇ filed an action in the United States
District Court for the Central District of California entitled ▇▇▇▇▇▇▇▇▇▇▇
▇. ▇▇▇▇▇▇, ET AL. V. ACACIA
RESEARCH CORPORATION, ET AL., USDC Case No. 96-5551 R (Ex) (the
"Action"). In the Action, the ▇▇▇▇▇▇ allege that Acacia and Whitewing
breached the Termination Agreement and the parties' prior agreements
concerning the Stock Options by refusing to permit the ▇▇▇▇▇▇ to exercise
any of the Stock Options.
(6) In October 1996, ▇▇▇▇▇▇ and ▇▇▇▇▇▇▇▇▇ filed a cross-complaint
for fraud, duress, and declaratory relief against the ▇▇▇▇▇▇ (the
"Cross-Action"). In the Cross-Action, Acacia and Whitewing seek a
judicial declaration that the Termination Agreement and Stock Options are
null and void, and also seek the return of money previously paid to the
▇▇▇▇▇▇.
(7) To avoid the expense and inconvenience of protracted litigation,
the parties desire to bring an end to the Action and the Cross-Action, and
to settle and release one another from all of the claims and disputes
between them.
II. SETTLEMENT OF CLAIMS
In full settlement of all their respective claims and in consideration
of the mutual promises set forth in this Settlement Agreement, the parties
agree:
A. CONSIDERATION BY ACACIA AND WHITEWING.
(1) Upon execution of this Settlement Agreement, ▇▇▇▇▇▇ will deliver
to the ▇▇▇▇▇▇ a check payable to the ▇▇▇▇▇▇ in the amount of $25,000.00.
(2) Upon execution of this Settlement Agreement, Acacia will grant
the ▇▇▇▇▇▇ nontransferable options to purchase an aggregate amount of
120,600 shares of Acacia common stock, in the form set forth on the Form of
Option Agreement, attached hereto as Exhibit A (the "Settlement Options").
These Settlement Options will not, however, vest to the ▇▇▇▇▇▇ immediately,
but instead will vest to the ▇▇▇▇▇▇ over time, according to the following
schedule: 6,700 Settlement Options will vest with the ▇▇▇▇▇▇ on the date of
execution of this Settlement Agreement; thereafter, during each of the next
17 months and on the monthly anniversary of the date of execution of this
Settlement Agreement, 6,700 additional Settlement Options will vest with
the ▇▇▇▇▇▇. These monthly issuances of Settlement Options are subject to
termination, and the aggregate amount of Settlement Options exercisable by
the ▇▇▇▇▇▇ is subject to reduction, pursuant to the terms of Paragraph
II.A.(3) below. The exercise price of all of the Settlement Options (I.E.,
the price the ▇▇▇▇▇▇ will pay Acacia for a share of Acacia common stock if
they choose to exercise any of the Settlement Options) will be fixed at 15%
below the average selling price of a share of Acacia common stock (on the
Nasdaq National Market System) on the date the Settlement
2
Options are granted.
(3) Any Settlement Options not exercised by the ▇▇▇▇▇▇ within 18
months of the date of execution of this Settlement Agreement will
automatically expire on the 18th-month anniversary of the date of execution
of this Settlement Agreement. Upon the expiration of the unexercised
Settlement Options, Acacia will pay the ▇▇▇▇▇▇ the sum of $475,000.00 (the
"Settlement Amount"), which sum will be reduced by any profits realized by
the ▇▇▇▇▇▇ through the exercise of any of the Settlement Options (without
offsetting or otherwise considering any transaction which results in a
monetary loss to the ▇▇▇▇▇▇). For purpose of this Paragraph, the amount of
profit realized by the ▇▇▇▇▇▇ through the exercise of a Settlement Option
will be calculated by subtracting the exercise price of the Option from the
average selling price of a share of Acacia common stock (on the Nasdaq
National Market System) on the date of exercise. Thus, for example, if the
exercise price of the Settlement Options were fixed at $7.00 per share, and
the ▇▇▇▇▇▇ exercise 10,000 Settlement Options on a date when the average
selling price of a share of Acacia common stock were $10.00 per share, the
▇▇▇▇▇▇ would realize profits of $30,000.00 from the exercise of the
Options, and the Settlement Amount would be reduced by this $30,000.00.
If, at any time prior to the date on which the Settlement Amount becomes
due and owing, the ▇▇▇▇▇▇ have realized total profits of $475,000.00 from
the exercise of Settlement Options, then Acacia's obligation to pay any of
the Settlement Amount will automatically terminate, Acacia's obligation to
issue any additional Settlement Options to the ▇▇▇▇▇▇ will automatically
terminate, and any unexercised Settlement Options previously issued to the
▇▇▇▇▇▇ will automatically become null and void.
(4) Except as provided in Paragraph II.A.(3) above, the ▇▇▇▇▇▇ may at
any time exercise any of the Settlement Options that have been vested, but
they need not exercise any Settlement Options at any time, and their right
to exercise Settlement Options will accumulate as the Options are issued to
them on a monthly basis.
(5) The ▇▇▇▇▇▇ will be entitled to registration rights with respect
to the common stock issued to them upon exercise of the Settlement Options
in accordance with the terms set forth on Exhibit B attached hereto.
(6) Upon execution of this Settlement Agreement, Acacia and ▇▇▇▇▇▇▇▇▇
will stipulate to the dismissal with prejudice of the Cross-Action, with
each party to bear its own costs and attorneys' fees.
B. CONSIDERATION BY THE ▇▇▇▇▇▇.
(1) Upon execution of this Settlement Agreement, the
3
▇▇▇▇▇▇ will stipulate to the dismissal with prejudice of the Action, with
each party to bear its own costs and attorneys' fees.
III. MUTUAL WAIVERS AND RELEASES
A. RELEASE OF ALL CLAIMS. Except as to the obligations of the parties
under this Settlement Agreement, and in further consideration for the execution
of this Settlement Agreement:
(1) Acacia, on behalf of itself and its partners, parents,
subsidiaries, divisions, affiliates, officers, directors, shareholders,
investors, employees, representatives, agents, attorneys, transferors,
transferees, predecessors, successors, and assigns, hereby forever and
fully releases and discharges the ▇▇▇▇▇▇, and each of their respective
partners, employees, representatives, agents, attorneys, transferors,
transferees, predecessors, successors, and assigns from any and all claims,
rights, demands, liens, agreements, contracts, warranties, covenants,
actions, suits, causes of action, obligations, controversies, debts, costs,
attorneys' fees, expenses, accounts, damages, judgments, orders, and
liabilities of whatever kind or nature in law, equity, or otherwise,
whether known or unknown, suspected or unsuspected, anticipated or
unanticipated, liquidated or unliquidated, and whether or not concealed or
hidden, which exist, may exist, have existed, or may have existed, or which
hereafter can, will, or may exist, based on any facts, events, or omissions
occurring prior to the date hereof, including but not limited to claims
asserted in the Cross-Action.
(2) ▇▇▇▇▇▇▇▇▇, on behalf of itself and its partners, parents,
subsidiaries, divisions, affiliates, officers, directors, shareholders,
investors, employees, representatives, agents, attorneys, transferors,
transferees, predecessors, successors, and assigns, hereby forever and
fully releases and discharges the ▇▇▇▇▇▇, and each of their respective
partners, employees, representatives, agents, attorneys, transferors,
transferees, predecessors, successors, and assigns from any and all claims,
rights, demands, liens, agreements, contracts, warranties, covenants,
actions, suits, causes of action, obligations, controversies, debts, costs,
attorneys' fees, expenses, accounts, damages, judgments, orders, and
liabilities of whatever kind or nature in law, equity, or otherwise,
whether known or unknown, suspected or unsuspected, anticipated or
unanticipated, liquidated or unliquidated, and whether or not concealed or
hidden, which exist, may exist, have existed, or may have existed, or which
hereafter can, will, or may exist, based on any facts, events, or omissions
occurring prior to the date hereof, including but not limited to claims
asserted in the Cross-Action.
(3) The ▇▇▇▇▇▇, on behalf of themselves and their
4
respective partners, employees, representatives, agents, attorneys,
transferors, transferees, predecessors, successors, and assigns, hereby
forever and fully release and discharge Acacia and each of its partners,
parents, subsidiaries, divisions, affiliates, officers, directors,
shareholders, investors, employees, representatives, agents, attorneys,
transferors, transferees, predecessors, successors, and assigns from any
and all claims, rights, demands, liens, agreements, contracts,
warranties, covenants, actions, suits, causes of action, obligations,
controversies, debts, costs, attorneys' fees, expenses, accounts,
damages, judgments, orders, and liabilities of whatever kind or nature in
law, equity, or otherwise, whether known or unknown, suspected or
unsuspected, anticipated or unanticipated, liquidated or unliquidated,
and whether or not concealed or hidden, which exist, may exist, have
existed, or may have existed, or which hereafter can, will, or may exist,
based on any facts, events, or omissions occurring prior to the date
hereof, including but not limited to claims asserted in the Action.
(4) The ▇▇▇▇▇▇, on behalf of themselves and their respective
partners, employees, representatives, agents, attorneys, transferors,
transferees, predecessors, successors, and assigns, hereby forever and
fully release and discharge Whitewing, and each of its partners, parents,
subsidiaries, divisions, affiliates, officers, directors, shareholders,
investors, employees, representatives, agents, attorneys, transferors,
transferees, predecessors, successors, and assigns from any and all claims,
rights, demands, liens, agreements, contracts, warranties, covenants,
actions, suits, causes of action, obligations, controversies, debts, costs,
attorneys' fees, expenses, accounts, damages, judgments, orders, and
liabilities of whatever kind or nature in law, equity, or otherwise,
whether known or unknown, suspected or unsuspected, anticipated or
unanticipated, liquidated or unliquidated, and whether or not concealed or
hidden, which exist, may exist, have existed, or may have existed, or which
hereafter can, will, or may exist, based on any facts, events, or omissions
occurring prior to the date hereof, including but not limited to claims
asserted in the Action.
(The claims identified in subparagraphs III.A.(1), III.A.(2),
III.A.(3), and III.A.(4) above are collectively referred to herein as the
"Released Claims.")
▇. ▇▇▇▇▇▇ OF OTHER CLAIMS. The parties each acknowledge that there is a
possibility that, subsequent to the execution of this Settlement Agreement, they
will discover facts or incur or suffer claims which were unknown or unsuspected
at the time this Settlement Agreement was executed, and which if known by them
at that time may have materially affected their decision to execute this
Settlement Agreement. The parties acknowledge and agree that by reason of this
Settlement Agreement and the releases of the Released Claims, they are assuming
any risk of such unknown facts
5
and such unknown and unsuspected claims. The parties have each been advised
of the existence of Section 1542 of the California Civil Code, which provides:
A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH
A CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN
HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE,
WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY
AFFECTED HIS SETTLEMENT WITH A DEBTOR.
Notwithstanding such provisions, this Settlement Agreement will constitute a
full and mutual release in accordance with its terms. Each of the parties
knowingly and voluntarily waive the provisions of Section 1542, as well as
any other statute, law, or rule of similar effect, and acknowledge and agree
that this waiver is an essential and material term of this Settlement
Agreement, and that without such waiver the Settlement Agreement would not
have been entered into. The parties hereby represent that they have been
advised by their legal counsel, and understand and acknowledge the
significance and consequence of their releases and of this specific waiver of
Section 1542 and other such laws.
IV. REPRESENTATIONS AND WARRANTIES OF THE ▇▇▇▇▇▇
A. REPRESENTATIONS AND WARRANTIES. Each of the ▇▇▇▇▇▇ severally
represents and warrants to Acacia and to each other that such person:
(1) is acquiring the Settlement Options for such person's
own account as an investment and without an intent to distribute;
(2) acknowledges that the Settlement Options have not been
registered under the Securities Act of 1933, as amended, or any
state securities laws, and that the Settlement Options and any
shares of Acacia common stock received upon exercise of the
Settlement Options may not be resold or transferred by such
person without appropriate registration or the availability of an
exemption from such requirements; and
(3) has such knowledge and experience in business and
financial matters in general as to be capable of evaluating
Acacia, its proposed activities, and the risks and merits of an
investment in the Settlement Options and any shares of Acacia
common stock received upon exercise of the Settlement Options.
By making payment for any Acacia common stock received upon exercise
of any Settlement Option, or by taking delivery of any Settlement
Option or any Acacia common stock, each of the ▇▇▇▇▇▇ will be deemed
to have reaffirmed such representation and warranty at and as of the
date of such payment or delivery.
6
V. MISCELLANEOUS PROVISIONS
A. DISCLAIMER OF LIABILITY. Nothing in this Settlement Agreement will
be construed as an express or implied admission or acknowledgment by the
parties that they have any liability to one another in connection with the
Action.
B. CONFIDENTIALITY. The parties agree to keep the terms and conditions
of this Settlement Agreement confidential, and will not disclose its terms or
conditions to anyone other than their respective professional business,
accounting, and legal advisors (who will similarly keep the terms and
conditions of this Settlement Agreement confidential), except as required by
law. The parties hereto acknowledge that Acacia is subject to the securities
laws as a publicly-traded company and will therefore be required to disclose
all or portions of this Agreement in accordance with applicable securities
laws.
C. ADDITIONAL DOCUMENTATION AND COOPERATION WITH FURTHER PROCEEDINGS.
The parties agree to promptly execute such additional documentation, and to
cooperate in further proceedings necessary to effectuate the terms of this
Settlement Agreement, without charge or other consideration.
D. NO ASSIGNMENT OF CLAIMS. The parties represent to one another that
they have not assigned, transferred, or encumbered any of the Released
Claims. Each of the parties agrees to indemnify and hold harmless each of
the others from any liabilities, claims, demands, damages, costs, expenses,
and attorneys' fees incurred by the others as a result of any person
asserting such an assignment or transfer.
E. TAX WITHHOLDING. Upon exercise of any Settlement Option, the ▇▇▇▇▇▇
shall pay to Acacia any taxes on income or gain or other charges which the
▇▇▇▇▇▇ may be required to pay or the Company may be required to withhold with
respect to such event.
F. AUTHORITY OF NON-INDIVIDUAL PARTIES. Acacia and ▇▇▇▇▇▇▇▇▇ represent
to the ▇▇▇▇▇▇ that they each have the authority to enter into this Settlement
Agreement on behalf of themselves and their respective directors,
shareholders, and/or partners. Each of these non-individual parties agrees
to indemnify and hold harmless the ▇▇▇▇▇▇ from any liabilities, claims,
demands, damages, costs, expenses, and attorneys' fees incurred as a result
of any person or entity asserting a lack of such authority.
G. INTEGRATION AND MUTUAL REPRESENTATIONS. This Settlement
Agreement constitutes the entire agreement and understanding between
the parties concerning the subject matter hereof, and supersedes and
replaces all prior negotiations, proposed agreements, and agreements,
written or oral, relating thereto. Each of the parties has read this
Settlement Agreement and understands the contents thereof. Each of
the parties has made
7
such an investigation of the facts pertinent to this Settlement Agreement and
all of the matters pertaining to it as they deemed necessary. Each of the
parties acknowledges that, in entering into this Settlement Agreement, it has
not relied on any representation made by any party that is not contained in
this Settlement Agreement. Each of the parties acknowledges that it has been
represented by legal counsel of its own choice throughout all negotiations
which preceded the execution of this Settlement Agreement, and that it has
executed this document with the advice and consent of such legal counsel.
H. GOVERNING LAW. The parties acknowledge and agree that the laws of
the State of California govern their rights under this Settlement Agreement.
All questions concerning the construction of this Settlement Agreement and
the rights and liabilities of the parties hereunder will be governed by the
laws of the State of California in effect as of the date hereof (without
giving effect to the conflicts of laws principles thereof), and this
Settlement Agreement will be deemed to have been executed and performed in
the County of Los Angeles. Should any action or other proceeding be
necessary to enforce any of the provisions of this Settlement Agreement, the
action will be filed in state or federal court in the County of Los Angeles.
I. ATTORNEYS' FEES. Should any action or other proceeding be necessary
to enforce any of the provisions of this Settlement Agreement, the prevailing
party will be entitled to recover its costs and reasonable attorneys' fees.
J. BINDING EFFECT. This Settlement Agreement will be binding on and
inure to the benefit of the parties and their successors in interest, their
predecessors in interest, and their assigns.
K. AMENDMENTS. This Settlement Agreement may be amended, modified,
canceled, or waived only by written instrument executed by each of the
parties.
L. UNENFORCEABLE TERMS. If any provision of this Settlement Agreement
is adjudicated to be unenforceable or invalid for any reason, that part will
be severed from the balance of this Settlement Agreement and the validity and
enforceability of the remainder of this Settlement Agreement will in no way
be affected or impaired, unless the severed portion was essential to the
intended purpose of this Settlement Agreement. If the severed portion was
essential to the intended purpose of this Settlement Agreement, then the
party who was to receive the benefit of the severed portion has the option to
void this Settlement Agreement. The parties expressly agree that paragraphs
II.A.(1), II.A.(2), II.A.(3), II.A.(4), II.A.(5), II.A.(6), II.B.(1),
III.A.(1), III.A.(2), III.A.(3), III.A.(4), III.B., IV.A.(1), IV.A.(2),
IV.A.(3), and IV.A.(4) are each essential to the intended purpose of this
Settlement Agreement.
8
▇. ▇▇▇▇▇▇ OF TERMS. A waiver of any term or condition of this
Settlement Agreement will not be deemed to be, and may not be construed as, a
waiver of any other term or condition hereof.
N. NEUTRAL CONSTRUCTION. This Settlement Agreement will be construed
neutrally, and will not be applied more strictly against one party than
another.
O. EXECUTION IN COUNTERPARTS. This Settlement Agreement may be
executed in any number of counterparts, which together will constitute one
instrument.
IN WITNESS WHEREOF, the undersigned have executed this ten-page
(excluding exhibits) Settlement Agreement as of May 7, 1997.
ACACIA RESEARCH CORPORATION
By /s/ ▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇
-----------------------------
Its Chief Financial Officer
-----------------------------
WHITEWING LABS, INC.
By /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
-----------------------------
Its President
-----------------------------
Approved as to Form:
O'MELVENY & ▇▇▇▇▇ LLP
▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
By /S/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇
-------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇▇
Attorneys for ACACIA RESEARCH
CORPORATION and WHITEWING LABS, INC.
9
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
-----------------------------
▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
/s/ ▇▇▇ ▇. ▇▇▇▇▇▇
-----------------------------
▇▇▇ ▇. ▇▇▇▇▇▇
Approved as to Form:
AKERMAN, SENTERFITT & ▇▇▇▇▇▇, P.A.
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
By /s/ ▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
------------------------------------
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
Attorneys for ▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
and ▇▇▇ ▇. ▇▇▇▇▇▇
10
EXHIBIT A
NON-TRANSFERABLE, NONQUALIFIED STOCK OPTION AGREEMENT
THIS AGREEMENT dated as of the 7th day of May, 1997, between Acacia
Research Corporation, a California corporation (the "Company"), and
▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ and ▇▇▇ ▇. ▇▇▇▇▇▇ (the "▇▇▇▇▇▇").
W I T N E S E T H
WHEREAS, pursuant to the terms of the Settlement Agreement with the
▇▇▇▇▇▇ dated May 7, 1997 (the "Settlement Agreement"), the Company has
granted to the ▇▇▇▇▇▇ effective as of the date hereof (the "Option Date") a
stock option to purchase authorized but unissued or treasury shares of Common
Stock of the Company (the "Common Stock"), upon the terms and subject to the
conditions set forth herein.
NOW, THEREFORE, in consideration of the execution of the Settlement
Agreement, the mutual promises and covenants made herein and therein and the
mutual benefits derived, the parties agree as follows:
1. DEFINED TERMS. Capitalized terms used herein and not otherwise
defined herein shall have the meaning assigned to such terms in the
Settlement Agreement. The term "Shares", as used herein, refers to shares of
the Common Stock and of any stock or any other securities or property into
which the Shares may hereafter be changed.
2. GRANT OF OPTION; EXERCISE PRICE; VESTING LIMITS. (a) This
Agreement evidences the Company's grant to the ▇▇▇▇▇▇ of the right and option
to purchase, subject to the terms and conditions set forth herein, all or any
part of an aggregate of 120,600 shares of the Common Stock (the "Option") at
a price per share of $4.25 (as from time to time adjusted hereunder, the
"Exercise Price"), representing a price equal to 85% of the fair market value
of the Common Stock on the date hereof.
(b) The Option shall vest and may be exercised as follows: 6700
Shares (subject to adjustment pursuant to Section 7 of this Agreement) on the
date of this Agreement, and 6700 Shares (subject to adjustment pursuant to
Section 7 of this Agreement) on each of the successive seventeen monthly
anniversaries of the date of this Agreement thereafter.
(c) Once exercisable, the Option may be exercised, from time to
time, in whole or in part, prior to the close of business on November 7,
1998, subject to earlier termination under Section 7 below, and subject to
reduction or termination pursuant to Section 2(d) below (the earliest of such
dates, the "Expiration
A-1
Date"). The Exercise Price and the number of Shares purchasable upon
exercise of the Option shall be subject to adjustment as provided in Section
7.
(d) Options with respect to any Shares not exercised by the ▇▇▇▇▇▇
prior to the Expiration Date automatically expire on such Expiration Date.
If, at any time prior to the Expiration Date, the ▇▇▇▇▇▇ have realized total
profits of $475,000.00 from the exercise of Options as calculated in
accordance with Paragraph II.A.(3) of the Settlement Agreement, then the
Option (or such portion of the Option which, if exercised, would increase the
▇▇▇▇▇▇' profit under such calculation to an amount in excess of $475,000.00)
shall thereupon cease vesting, and any unexercised Options previously issued
to the ▇▇▇▇▇▇ will automatically become null and void.
(e) Except as provided in Section 2(d) above, the ▇▇▇▇▇▇ may at any
time exercise all or any part of the Options that have vested, but they need
not exercise all or any part of the Options at any time, and their right to
exercise the Options will accumulate as the Options vest in accordance with
this Agreement.
(f) The ▇▇▇▇▇▇ will be entitled to registration rights with respect
to the Shares in accordance with the terms set forth in the Settlement
Agreement.
3. EXERCISABILITY OF OPTION. Upon payment in cash, bank cashier's
check or by wire transfer of the Exercise Price, the Company shall cause to
be delivered to the ▇▇▇▇▇▇ one or more certificates for the Shares so
purchased. The certificate shall be deemed to have been issued as of the
date of the surrender of the Option as to such number of Shares for which the
Exercise Price has been paid. If less than all of the Option is exercised,
the ▇▇▇▇▇▇ or the Company may request an exchange of this Agreement for a new
option agreement in substantially the same form in respect of the remaining
number of Shares subject to the Option. No fewer than 1000 Shares may be
purchased at any one time, unless the number purchased is the total number at
the time remaining for purchase under the Option. No adjustment shall be
made for any cash dividends declared or paid on Shares issuable on the
exercise of the Option.
4. METHOD OF EXERCISE OF OPTION. The Option may be exercised only
by the delivery to the Company of a written executed notice substantially in
the form of EXHIBIT I hereto stating the number of Shares as to which it is
being exercised and accompanied by payment in full in cash, bank cashier's
check or by wire transfer, of an amount equal to the Exercise Price per Share
multiplied by the number of Shares to be purchased, plus an amount sufficient
to pay all withholding or other taxes or charges associated with such
exercise.
5. COMPLIANCE WITH LAWS.
A-2
(a) SECURITIES LAWS. The issuance and delivery of the Shares are
subject to compliance with all applicable federal and state securities laws,
and to such approvals by any listing, regulatory or governmental authority as
may be necessary in connection therewith. Any securities delivered under this
Agreement shall be subject to such restrictions, and the person acquiring
such securities shall, if requested by the Company, provide such assurances
and representations to the Company as the Company may reasonably deem
necessary or advisable to assure compliance with such legal requirements.
Optionee acknowledges that it is acquiring the Option and if applicable any
of the Shares for investment purposes and not with a view to or for sale in
connection with the distribution thereof. Neither the Option nor the Shares
have been registered under the 1933 Act or any state securities laws. Prior
to their registration, the Shares will be considered "restricted securities"
under Rule 144 under the 1933 Act and neither the Shares nor any interest
therein may be sold or otherwise disposed of without such registration or an
opinion of counsel to the Company that an exemption from applicable
registration requirements is available. Any permitted transferee shall be
subject to similar restrictions.
(b) TAX WITHHOLDING. Upon exercise of the Option, the ▇▇▇▇▇▇ shall
pay to the Company any taxes on income or gain or other charges which the
▇▇▇▇▇▇ may be required to pay or the Company may be required to withhold with
respect to such event.
(c) PAYMENT OF TAXES. The Company shall pay all documentary stamp
taxes, if any, attributable to this Agreement or the issuance of any of the
Shares or other securities upon the exercise of the Option, PROVIDED,
HOWEVER, that the Company shall not be required to permit (or to pay any tax
or taxes which may be payable in respect of) any transfer involved in the
issue of any certificate for Shares in a name other than that of the ▇▇▇▇▇▇.
(d) RESERVATION OF SHARES. The Company will at all times reserve
and keep available, free from preemptive rights, out of the aggregate of its
authorized but unissued Shares or its authorized and issued Shares held in
its treasury, for the purpose of enabling it to satisfy any obligation to
issue Shares upon exercise of the Option, the full number of Shares
deliverable upon exercise of the Option.
6. NON-TRANSFERABILITY OF OPTION. The Option and any other rights
of the ▇▇▇▇▇▇ under this Agreement are exercisable only by the ▇▇▇▇▇▇, are
nontransferable and shall not be subject in any manner to anticipation,
alienation, sale, transfer, assignment, pledge, encumbrance or charge (other
than to the Company), except by operation of law or by will or the laws of
descent and distribution. The Company may disregard any attempt at transfer,
assignment or other alienation prohibited hereby.
7. ADJUSTMENT OF EXERCISE PRICE, NUMBER OF SHARES
A-3
PURCHASABLE. The Exercise Price and the number of Shares purchasable upon
the exercise of the Option are subject to adjustment by action both of the
Board of Directors of the Company from time to time as provided in this
Section 7.
(a) ADJUSTMENT EVENTS. If there shall occur any stock split,
dividend payable in stock, reverse stock split, merger or other
reorganization, or exchange of Shares or other securities of the Company, or
there shall occur any other fundamental change or event in respect of the
Shares or a sale of substantially all the assets of the Company as an
entirety, then the Board of Directors shall
(i) equitably and proportionately adjust (i) the number and type
of Shares (or other securities or property) subject to the
then outstanding Option, (ii) the exercise price of the
Option, and (iii) the securities and/or property deliverable
upon exercise of the Option; or
(ii) in the case of a merger or other reorganization that the
Company does not survive, or a sale of substantially all of
the assets of the Company as an entirety, provide for the
substitution or exchange of the Option (or the Shares
deliverable on exercise of the Option) for a right to
acquire the consideration payable to holders of other Shares
of the Company upon or in respect of such event subject to
the continuing limitations on vesting and exercise in
Section 2.
If, in the case of any such event, the stock or other securities or
property receivable on common shares by shareholders of the Company includes
shares of stock or other securities or property of or from an entity other
than a successor legally bound hereby, such other entity shall execute and
deliver for the benefit of the ▇▇▇▇▇▇ an agreement to be bound hereby,
together with such additional provisions to protect the interests of the
▇▇▇▇▇▇ as the Board of Directors shall reasonably consider necessary by
reason of the foregoing.
In the event of a merger or other reorganization that the Company
does not survive, or a sale of substantially all of the assets of the Company
as an entirety, the Board of Directors may in its discretion determine that
each Option shall become immediately exercisable, and Shares shall
immediately vest free of restrictions. Any acceleration of Awards shall
comply with applicable legal requirements. If any Option or other right to
acquire Shares under this Agreement has been so accelerated, but the ▇▇▇▇▇▇
fail to exercise such Option prior to the consummation of such reorganization
or sale, such Option or right shall thereupon terminate.
The provisions of this Section 7 shall bind the ▇▇▇▇▇▇ to
all adjustments or substitutions made by the Board of Directors in
A-4
good faith in accordance with the terms hereof and shall apply to any
successive recapitalization, reorganization or other referenced events.
(b) NO SHAREHOLDER RIGHTS. Nothing contained in this Agreement
shall be construed as conferring upon the ▇▇▇▇▇▇ (i) any right to vote or
receive dividends or rights or to be deemed for any purpose the holder of
Shares or of any other securities of the Company which may at any time be
issuable on the exercise of the Option, (ii) any other rights of a
shareholder of the Company, (iii) any right to vote upon any matter submitted
to shareholders at any meeting thereof, (iv) any authority to give or
withhold consent to any corporate action, or (v) to receive notice of
meetings, until the Option shall have been duly exercised as provided herein.
(c) EFFECTIVE DATE. Except as provided herein, adjustments under
Section 7(a) shall become effective immediately after the record date for the
determination of shareholders entitled to receive the applicable rights
contemplated thereby. Nevertheless, the Company may elect to defer the
effectiveness of such adjustment (but in no event to a date later than the
effective time of the event giving rise to such adjustment), in which case
the Company shall, with respect to any Option exercised after such record
date and before such adjustment shall have become effective (i) defer issuing
the number of Shares or other securities or deliverable upon such exercise in
excess of the number of Shares or other securities or property of the Company
issuable thereupon prior to adjustment, and (ii) not later than five business
days after such adjustment shall have become effective issue to such holder
the additional Shares or other securities or property issuable on such
exercise.
(d) DE MINIMIS EXCEPTION. No adjustment in the Exercise Price
shall be required unless such adjustment would require an increase or
decrease of at least 1% of the Exercise Price per Share; PROVIDED, that any
adjustments which by reason of this Section 7(d) are not required to be made
shall be carried forward and taken into account in any subsequent adjustment.
All calculations under this Section 7 shall be made to the nearer cent or to
the nearer one-hundredth of a Share, as the case may be. The Company shall
not be required to issue any fractional share, but any fractional share
interest shall be paid in cash equal to the fair market value of the
applicable percentage of a share in lieu thereof or, at the Company's
election, paid in a fractional or whole Share.
(e) FORM. Irrespective of any adjustments in the exercise price or
the number or kind of shares that may be acquired upon the exercise of the
Option, this Agreement may continue to express the same Exercise Price per
share and number and kind of Shares as are originally set forth in this
Agreement.
A-5
8. NO RESTRICTIONS ON CORPORATE AUTHORITY; TERMINATION OF OPTION
ON LIQUIDATION OF THE COMPANY. The provisions of this Agreement shall not be
deemed to restrict in any way any rights of the shareholder(s) or the Board,
acting in good faith, during the term of this Agreement to dissolve,
reorganize or take any other action or make any other change (fundamental or
otherwise) affecting the structure, existence, organization, operations or
business of the Company or any of its subsidiaries. This Option and all
rights hereunder shall terminate if the Option is not exercisable or
exercised prior to a dissolution of the Company. All decisions, including
adjustments, by the Board or the Board of Directors made in good faith under
this Agreement shall be binding and conclusive on the ▇▇▇▇▇▇.
9. NOTICES. Any notice to be given under the terms of this
Agreement shall be in writing and addressed to the Company at its principal
offices located at ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ to the
attention of the Chief Financial Officer and Corporate Secretary, and to the
▇▇▇▇▇▇ at the address given beneath their signatures hereto, or to such other
address as either party may hereafter designate in writing delivered to the
other party expressly for such purposes.
10. AMENDMENTS. This Agreement may be amended only by a writing
signed by the Company and the ▇▇▇▇▇▇.
11. SUCCESSORS; BENEFIT. All the covenants and provisions of this
Agreement by or for the benefit of the Company or the ▇▇▇▇▇▇ shall bind and
inure to the benefit of their respective successors and permitted assigns
hereunder. Nothing in this Agreement shall be construed to give to any
person or corporation other than the Company and the ▇▇▇▇▇▇ any legal or
equitable right, remedy or claim under this Agreement; and this Agreement
shall be for the sole and exclusive benefit of the Company, the ▇▇▇▇▇▇ and
any such permitted assigns or successors.
12. TERMINATION. This Agreement shall terminate at the close of
business on the Expiration Date. Notwithstanding the foregoing, this
Agreement will terminate upon the exercise of the Option in accordance with
these terms, in its entirety.
13. GOVERNING LAW. THIS AGREEMENT AND THE OPTION SHALL BE DEEMED
TO BE A CONTRACT MADE UNDER THE LAWS OF THE STATE OF CALIFORNIA AND FOR ALL
PURPOSES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF
SUCH STATE APPLICABLE TO CONTRACTS TO BE MADE AND PERFORMED ENTIRELY WITHIN
SUCH STATE, SUBJECT TO THE GENERAL CORPORATION LAW OF THE STATE OF
INCORPORATION OF THE COMPANY AS TO MATTERS GOVERNED THEREBY AS A MATTER OF
CORPORATION LAW.
14. COUNTERPARTS. This Agreement may be executed in any
number of counterparts and each of such counterparts shall for all
purposes be deemed to be an original, and all such counterparts
A-6
shall together constitute but one and the same instrument.
15. HEADINGS. The headings used in this Agreement are inserted for
convenience only and neither constitute a portion of this Agreement nor in
any manner affect the construction of the provisions of this Agreement.
16. EFFECTIVE DATE. This Agreement and the Option evidenced hereby
shall be granted as of the Effective Date and subject to the effectiveness of
the Settlement Agreement.
17. NONQUALIFIED STOCK OPTION. The Option are not, and are not
intended as, incentive stock options within the meaning of Section 422 of the
Internal Revenue Code of 1986, as amended.
A-7
IN WITNESS WHEREOF, the Company has caused this Agreement to be
executed on its behalf by a duly authorized officer and the ▇▇▇▇▇▇ have duly
executed this Agreement.
ACACIA RESEARCH CORPORATION, a
California corporation
By /s/ ▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇
--------------------------------
Title Chief Financial Officer
-----------------------------
▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
/s/ ▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
----------------------------------
----------------------------------
(Address)
----------------------------------
(City, State, Zip Code)
▇▇▇ ▇. ▇▇▇▇▇▇
/s/ ▇▇▇ ▇. ▇▇▇▇▇▇
----------------------------------
----------------------------------
(Address)
----------------------------------
(City, State, Zip Code)
A-8
Notational Record of Exercise:
-----------------------------------------------------------------
-----------------------------------------------------------------
Date Number of Shares Amount Received
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
-----------------------------------------------------------------
A-9
EXHIBIT I
FORM OF EXERCISE OF OPTION
( TO BE EXECUTED UPON ANY EXERCISE OF OPTION )
The undersigned hereby irrevocably elects [check applicable
box(es)]
/ / To exercise the rights, evidenced by the Non-Transferable,
Nonqualified Stock Option Agreement dated as of ____________ ___, 1997 (the
"Agreement"), to purchase _________ shares (the "Shares") and herewith
tenders payment in full for such Shares as follows: [check applicable box]
/ / by certified or official bank check payable to the order of
Acacia Research Corporation (the "Company") in the amount of $______________
/ / by wire transfer to _______________________
in accordance with the terms of the Agreement and instructions from the Chief
Financial Officer of the Company.
The ▇▇▇▇▇▇ request that a certificate for such Shares be registered to the
▇▇▇▇▇▇ and delivered to: ___________________________________.
If said number of Shares is less than all of the shares purchasable under the
Agreement, the ▇▇▇▇▇▇ shall deliver the Agreement to the Company so that the
Company can make notation of the partial exercise and the date hereof on the
executed copies of the Agreement.
The Shares may be sold or otherwise transferred only in compliance
with the Securities Act of 1933 and any applicable state laws and that
the Shares are legended to assure compliance with such laws. The
▇▇▇▇▇▇ severally represent that each of them
A-1
will comply with the Agreement and all applicable securities laws as to any
transactions in or with respect to the Shares.
Dated: , 199
--------- --- --
▇▇▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------
---------------------------
Insert Taxpayer I.D. No.
of ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇)
▇▇▇ ▇. ▇▇▇▇▇▇
---------------------------
---------------------------
Insert Taxpayer I.D. No.
of ▇▇▇ ▇. ▇▇▇▇▇▇)
To be completed by the Company after the price and receipt of funds
verified:
ACCEPTED BY:
ACACIA RESEARCH CORPORATION,
a California corporation
By:
----------------------------
Its:
----------------------------
A-2
EXHIBIT B
PROCEDURES FOR THE
REGISTRATION OF SHARES
SECTION 1. DEMAND REGISTRATION RIGHTS.
(a) At any time, the ▇▇▇▇▇▇ may by written notice to Acacia request
that Acacia register under the Securities Act of 1933, as amended, all or a
portion of the Registrable Shares held by the ▇▇▇▇▇▇ (a "Demand
Registration") and, subject to the provisions of this Agreement, Acacia shall
use its reasonable best efforts to effect such registration on Securities and
Exchange Commission Form S-3, as promptly as shall be practicable; PROVIDED,
HOWEVER, that Acacia shall have no obligation under this Section 1(a) if the
sale of the shares by the ▇▇▇▇▇▇ is then covered under any other Registration
Statement that includes such shares on a continuing or other basis. For
purposes of this Agreement, (i) "Registrable Shares" means the shares of
Acacia's common stock issued or issuable upon exercise of a Settlement Option
and held by the ▇▇▇▇▇▇ from time to time. Any such share of common stock
will cease to be a Registrable Share when (a) a registration statement
covering a Registrable Share has been declared effective by the Securities
and Exchange Commission, or any other federal agency at the time
administering the Securities Exchange Act of 1934 or the Securities Act of
1933 (the "Commission"), and such share has been disposed of by the ▇▇▇▇▇▇
pursuant to such effective registration statement, (b) the Registrable Share
is transferred to another person, (c) such share (after initial issuance) is
held by Acacia or one of its subsidiaries or otherwise ceases to be
outstanding, or (d) such share may be traded without restriction pursuant to
paragraph (k) of Rule 144, if applicable; and (ii) "Registration Statement"
means any registration statement or comparable document under the Securities
Act through which a public sale or disposition of the Registrable Shares may
be registered, including the prospectus, amendments and supplements to such
registration statement, all exhibits, and all material incorporated by
reference or deemed to be incorporated by reference in such Registration
Statement.
(b) Each notice to Acacia shall set forth (i) the number of
shares to be sold by the ▇▇▇▇▇▇ and (ii) the proposed manner of sale.
Acacia shall have no obligation to effect any Demand Registration
under this Section 1 unless the number of Registrable Shares in such
Demand Registration shall be equal to at least 50,000 shares or, if
lesser, the remaining Registrable Shares, but not less than 10,000
shares. The maximum number of such demands under this Section 1 shall
be two (2); PROVIDED, HOWEVER, that no such demand may be made after
the Expiration Date. A Registration Statement will not count as a
Demand Registration hereunder unless it is declared effective by the
Commission and remains effective for at least ninety (90) days or such
shorter period which shall terminate when all of the Registrable
Shares covered by such Demand Registration have been
B-1
sold pursuant to such Demand Registration; PROVIDED, HOWEVER, that in the
event a Registration Statement is withdrawn at the request of the ▇▇▇▇▇▇,
they shall forfeit the demand registration rights granted pursuant to this
Section 1.
(c) Acacia shall have the sole right to determine whether any of
the Registrable Shares covered by a Demand Registration are to be sold in an
underwritten offering, and if Acacia so determines, Acacia alone shall have
the right to select the managing underwriter or underwriters to administer
the offering.
(d) If the managing underwriter of an underwritten offering under
this Section 1 advises Acacia in writing that in its opinion the number of
shares requested to be included in such registration exceeds the number which
can be sold in such offering, Acacia will include in such registration only
the number of shares which in the opinion of such underwriter can be sold and
may delay registering the balance of the shares in a non-underwritten
offering for up to 120 days.
SECTION 2. SUSPENSION OF EFFECTIVENESS. Acacia's obligations under Section
1 above shall not restrict its ability to suspend the effectiveness of, or
direct the ▇▇▇▇▇▇ not to offer or sell securities under, any Demand
Registration, at any time, for such reasonable period of time which Acacia
believes is necessary to prevent the premature disclosure of any events or
information having a material effect on Acacia. In addition, Acacia shall
not be required to keep any Demand Registration effective, or may, without
suspending such effectiveness, instruct the ▇▇▇▇▇▇ not to sell such
securities, during any period during which Acacia is instructed, directed,
ordered or otherwise requested by any governmental agency or self-regulatory
organization to stop or suspend such trading or sales.
SECTION 3. HOLDBACK AGREEMENT. In the event of any filing of a prospectus
supplement or the commencement of an underwritten public distribution of
Acacia's common stock under a Registration Statement, whether or not
Registrable Shares are included, the ▇▇▇▇▇▇ agree not to effect any public
sale or distribution of Acacia's common stock (except as part of such
underwritten public distribution), including a sale pursuant to Rule 144 or
Rule 144A under the Securities Act, during a period designated by Acacia in a
written notice duly given to the ▇▇▇▇▇▇, which period shall commence
approximately 14 days prior to the effective date of any such filing of such
prospectus supplement or the commencement of such underwritten public
distribution of such common stock under a Registration Statement and shall
continue for up to 134 consecutive days.
SECTION 4. REGISTRATION PROCEDURES. Except as otherwise expressly provided
herein, in connection with any registration of Registrable Shares pursuant to
this Agreement, Acacia shall, as expeditiously as possible:
B-2
(a) prepare and file with the Commission a Registration Statement on
Form S-3 with respect to such Registrable Shares and use its reasonable best
efforts to cause such Registration Statement to become effective as soon as
practicable thereafter; and before filing a Registration Statement or
prospectus or any amendments or supplements thereto, furnish to the ▇▇▇▇▇▇
copies of such Registration Statement and such other documents as proposed to
be filed (including copies of any document to be incorporated by reference
therein), and thereafter furnish to the ▇▇▇▇▇▇ such number of copies as may
be reasonably requested in writing by the ▇▇▇▇▇▇ of such Registration
Statement, each amendment and supplement thereto (including copies of any
document to be incorporated by reference therein), including all exhibits
thereto, the prospectus included in such registration statement (including
each preliminary prospectus), and, promptly after the effectiveness of a
Registration Statement, the definitive final prospectus filed with the
Commission;
(b) use its reasonable best efforts to register or qualify such
Registrable Shares under such other securities or blue sky laws of such
jurisdictions within the United States as the ▇▇▇▇▇▇ reasonably (in light of
the ▇▇▇▇▇▇' intended plan of distribution) requests; PROVIDED that Acacia
will not be required to (i) qualify generally to do business in any
jurisdiction where it would not otherwise be required to qualify but for this
Section (4)(b), (ii) subject itself to taxation in any such jurisdiction or
(iii) consent to general service of process in any such jurisdiction;
(c) notify the ▇▇▇▇▇▇, at any time when a prospectus relating
thereto is required to be delivered under the Securities Act, of the
occurrence of any event as a result of which the prospectus included in such
Registration Statement (including any document to be incorporated by
reference therein) contains an untrue statement of a material fact or omits
any fact necessary to make the statements therein not misleading and, at the
request of the ▇▇▇▇▇▇, Acacia shall prepare a supplement or amendment to such
prospectus so that, as thereafter delivered to the purchasers of such
Registrable Shares, such prospectus will not contain an untrue statement of a
material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading and
promptly make available to the ▇▇▇▇▇▇ any such supplement or amendment;
(d) notify the ▇▇▇▇▇▇ and the managing underwriters, if any,
promptly, and (if requested by any such Person) confirm such advice in
writing, (i) when the Registration Statement, the prospectus or any
prospectus supplement or post-effective amendment has been filed, and, with
respect to the Registration Statement or any post-effective amendment, when
the same has become effective, (ii) of the issuance by the Commission of any
stop order suspending the effectiveness of a Registration Statement or of any
order preventing or suspending the use of any preliminary prospectus or the
initiation of any proceedings for
B-3
that purpose and Acacia shall promptly use its reasonable best efforts to
prevent the issuance of any stop order or to obtain its withdrawal if such
stop order should be issued and (iii) of the receipt by Acacia of any
notification with respect to the suspension of the qualification or exemption
from qualification of a Registration Statement or any of the Registrable
Shares for offer or sale in any jurisdiction, or the initiation or
threatening of any proceeding for such purpose.
Acacia may require the ▇▇▇▇▇▇ to furnish to Acacia such information
regarding themselves and the distribution of such Registrable Shares as
Acacia may from time to time reasonably request in writing and such other
information as may be legally required in connection with such registration.
The ▇▇▇▇▇▇ agree, by their acquisition of Registrable Shares and its
acceptance of the benefits provided to it hereunder, to furnish promptly to
Acacia all information required to be disclosed in order to make any
previously furnished information not materially misleading.
The ▇▇▇▇▇▇ agree that upon receipt of any notice from Acacia of the
happening of any event of the kind described herein requiring the cessation
of the distribution of a prospectus or the distribution of a supplemented or
amended prospectus, the ▇▇▇▇▇▇ will forthwith discontinue disposition of
Registrable Shares pursuant to the Registration Statement covering such
Registrable Shares until the ▇▇▇▇▇▇'▇ receipt of the copies of the
supplemented or amended prospectus contemplated by this Agreement, or until
it is advised in writing by Acacia that the use of the prospectus may be
resumed, and, if so directed by ▇▇▇▇▇▇, the ▇▇▇▇▇▇ will deliver to Acacia (at
Acacia's expense) all copies, other than permanent file copies then in the
▇▇▇▇▇▇'▇ possession, of the prospectus covering such Registrable Shares
current at the time of receipt of such notice.
SECTION 5. REGISTRATION EXPENSES. All expenses incident to Acacia's
performance of or compliance with the registration of shares pursuant to this
Agreement, including, without limitation, all registration and filing fees,
fees and expenses of compliance with securities or "blue sky" laws (including
reasonable fees and disbursements of counsel of Acacia and counsel for the
underwriters in connection with "blue sky" qualifications of the Registrable
Shares), fees and expenses associated with filings required to be made with
the National Association of Securities Dealers, Inc., and with listing on any
national securities exchange or exchanges in which listing may be sought,
printing expenses, messenger and delivery expenses, fees and expenses of
counsel for Acacia and its independent certified public accountants,
securities acts liability insurance (if Acacia elects to obtain such
insurance), the fees and expenses of any special experts retained by Acacia
in connection with such registration, and fees and expenses of other persons
retained by Acacia (all such expenses being herein called "REGISTRATION
EXPENSES") will be borne by Acacia; PROVIDED that in no event shall
Registration Expenses payable by Acacia include any (i) underwriting
discounts, commissions, or fees attributable to the
B-4
sale of the Registrable Shares, (ii) fees and expenses of any counsel,
accountants, or other persons retained or employed by the ▇▇▇▇▇▇ or
underwriters, or (iii) transfer taxes, if any.
B-5
